Trisalus Life SciencesTLSI
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 31 institutions reported holding Trisalus Life Sciences Inc. (TLSI) in their 13F filings, up 4 from Q2 2024. 10 opened new positions and 6 sold out. The largest holders were Wealthcare Advisory Partners LLC ($3.0M), Duquesne Family Office ($2.0M) and Vanguard Group Inc. ($1.9M). 2 famous investors held it, including Stanley Druckenmiller (0.1% of Duquesne Family Office's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Trisalus Life Sciences Inc.
- CUSIP
- 89680M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $3.8M |
| Exits | 6 | $1.4M |
All 13F filers, Q2 2024 → Q3 2024: 878,679 shares bought and 492,588 shares sold, net +386,091 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Wealthcare Advisory Partners LLC | 0.08% | New | 643,740 | $3.0M |
| Duquesne Family Office | 0.07% | No change | 426,921 | $2.0M |
| Vanguard Group Inc. | 0.00% | No change | 416,138 | $1.9M |
| Geode Capital Management, LLC | 0.00% | Add +45.4% | 200,427 | $924K |
| Millennium Management | 0.00% | Reduce -20.4% | 97,888 | $451K |
| MSD Partners, L.P. | 0.12% | New | 39,999 | $184K |
| Exos Asset Management LLC | 87.75% | Reduce -77.0% | 38,604 | $178K |
| Lido Advisors, LLC | 0.00% | Reduce -21.1% | 35,024 | $161K |
| Connecticut Wealth Management, LLC | 0.01% | No change | 32,879 | $152K |
| BlackRock, Inc. | 0.00% | — | 30,270 | $140K |
| Northern Trust Corp. | 0.00% | No change | 26,176 | $121K |
| Vestcor Inc | 0.00% | New | 23,376 | $108K |
| Angelo Gordon & Co., L.P. | 0.03% | New | 20,854 | $96K |
| Virtu Financial LLC | 0.01% | New | 19,875 | $92K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 15,554 | $72K |
| HRT Financial LP | 0.00% | Reduce -56.2% | 15,575 | $71K |
| Bridgeway Capital Management, LLC | 0.00% | New | 15,000 | $69K |
| Gilder Gagnon Howe & Co. LLC | 0.00% | New | 14,440 | $67K |
| Walleye Capital LLC | 0.00% | New | 14,376 | $66K |
| Magnetar Financial LLC | 0.00% | New | 14,232 | $66K |
| State Street Corp. | 0.00% | No change | 11,100 | $51K |
| Two Sigma Securities, LLC | 0.00% | New | 10,192 | $47K |
| Wolverine Asset Management LLC | 0.00% | Reduce -89.1% | 4,748 | $22K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -71.2% | 1,703 | $8K |
| Morgan Stanley | 0.00% | Reduce -42.4% | 1,135 | $5K |
| Hoertkorn Richard Charles | 0.00% | No change | 668 | $3K |
| Bank of America Corp. | 0.00% | Add +48.0% | 148 | $682 |
| Signaturefd, LLC | 0.00% | No change | 100 | $461 |
| JPMorgan Chase & Co. | 0.00% | Add +25.0% | 25 | $115 |
| UBS Group AG | 0.00% | Reduce -98.9% | 22 | $101 |
| Wells Fargo & Company | 0.00% | Reduce -99.9% | 1 | $5 |
"% of holder's portfolio" is TLSI's weight in each manager's 13F, not the share of Trisalus Life Sciences Inc. the manager owns.